Catalytic inactivation of protein tyrosine phosphatase CD45 and protein tyrosine phosphatase 1B by polyaromatic quinones. 2004

Qingping Wang, and Daniel Dubé, and Richard W Friesen, and Tammy G LeRiche, and Kevin P Bateman, and Laird Trimble, and Joe Sanghara, and Rebecca Pollex, and Chidambaram Ramachandran, and Michael J Gresser, and Zheng Huang
Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Post Office Box 1005, Pointe Claire, Dorval, Quebec H9R 4P8, Canada.

Polyaromatic quinones, such as the environmental pollutants 9,10-phenanthrenediones, elicit a wide range of responses including growth inhibition, immune suppression, and glucose normalization in diabetic models. Yet the molecular mechanisms behind these effects remain controversial. Here we report that many of them are oxygen-dependent and catalytic inactivators of protein tyrosine phosphatases (PTP). Under aerobic conditions, the PTP inactivation by 2-nitro-9,10-phenanthrenedione followed a pseudo-first-order process, with the rate of inactivation increasing nearly linearly with increasing inhibitor concentration, yielding apparent inactivation rate constants of 4300, 387, and 5200 M(-1) s(-1) at pH 7.2 against CD45, PTP1B, and LAR, respectively. The rate of CD45 inactivation increased approximately 25-fold from pH 6.0 to 7.5, with complete inactivation achieved using a catalytic amount (0.05 molar equiv) of the inhibitor. The quinone-catalyzed CD45 inactivation was prevented by catalase or superoxide dismutase. Inactivated CD45 after (125)I-9,10-phenanthrenedione treatment carried no radioactivity, indicating the absence of a stable inhibitor/enzyme complex. The activity of inactivated CD45 was partially restored ( approximately 10%) by hydroxylamine or dithiothreitol, supporting the presence of a small population of sulfenic acid or sulfenyl-amide species. Treatment of PTP1B with 2-nitro-9,10-phenanthrenedione resulted in the specific and sequential oxidation of the catalytic cysteine to the sulfinic and sulfonic acid. These results suggest that reactive oxygen species and the semiquinone radical, continuously generated during quinone-catalyzed redox cycling, mediate the specific catalytic cysteine oxidation. Naturally occurring quinones may act as efficient regulators of protein tyrosine phosphorylation in biological systems. Aberrant phosphotyrosine homeostasis resulting from continued polyaromatic hydrocarbon quinone exposure may play a significant role in their disease etiology.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D010616 Phenanthrenes POLYCYCLIC AROMATIC HYDROCARBONS composed of three fused BENZENE rings.
D010750 Phosphoproteins Phosphoprotein
D011809 Quinones Hydrocarbon rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine
D004229 Dithiothreitol A reagent commonly used in biochemical studies as a protective agent to prevent the oxidation of SH (thiol) groups and for reducing disulphides to dithiols. Cleland Reagent,Cleland's Reagent,Sputolysin,Clelands Reagent,Reagent, Cleland,Reagent, Cleland's

Related Publications

Qingping Wang, and Daniel Dubé, and Richard W Friesen, and Tammy G LeRiche, and Kevin P Bateman, and Laird Trimble, and Joe Sanghara, and Rebecca Pollex, and Chidambaram Ramachandran, and Michael J Gresser, and Zheng Huang
November 2008, Bioorganic & medicinal chemistry letters,
Qingping Wang, and Daniel Dubé, and Richard W Friesen, and Tammy G LeRiche, and Kevin P Bateman, and Laird Trimble, and Joe Sanghara, and Rebecca Pollex, and Chidambaram Ramachandran, and Michael J Gresser, and Zheng Huang
September 2007, Chemical research in toxicology,
Qingping Wang, and Daniel Dubé, and Richard W Friesen, and Tammy G LeRiche, and Kevin P Bateman, and Laird Trimble, and Joe Sanghara, and Rebecca Pollex, and Chidambaram Ramachandran, and Michael J Gresser, and Zheng Huang
August 2001, The Journal of biological chemistry,
Qingping Wang, and Daniel Dubé, and Richard W Friesen, and Tammy G LeRiche, and Kevin P Bateman, and Laird Trimble, and Joe Sanghara, and Rebecca Pollex, and Chidambaram Ramachandran, and Michael J Gresser, and Zheng Huang
January 2003, Current topics in medicinal chemistry,
Qingping Wang, and Daniel Dubé, and Richard W Friesen, and Tammy G LeRiche, and Kevin P Bateman, and Laird Trimble, and Joe Sanghara, and Rebecca Pollex, and Chidambaram Ramachandran, and Michael J Gresser, and Zheng Huang
April 2017, Biochemistry,
Qingping Wang, and Daniel Dubé, and Richard W Friesen, and Tammy G LeRiche, and Kevin P Bateman, and Laird Trimble, and Joe Sanghara, and Rebecca Pollex, and Chidambaram Ramachandran, and Michael J Gresser, and Zheng Huang
February 2000, FEBS letters,
Qingping Wang, and Daniel Dubé, and Richard W Friesen, and Tammy G LeRiche, and Kevin P Bateman, and Laird Trimble, and Joe Sanghara, and Rebecca Pollex, and Chidambaram Ramachandran, and Michael J Gresser, and Zheng Huang
January 2007, Nature cell biology,
Qingping Wang, and Daniel Dubé, and Richard W Friesen, and Tammy G LeRiche, and Kevin P Bateman, and Laird Trimble, and Joe Sanghara, and Rebecca Pollex, and Chidambaram Ramachandran, and Michael J Gresser, and Zheng Huang
June 2018, American journal of physiology. Heart and circulatory physiology,
Qingping Wang, and Daniel Dubé, and Richard W Friesen, and Tammy G LeRiche, and Kevin P Bateman, and Laird Trimble, and Joe Sanghara, and Rebecca Pollex, and Chidambaram Ramachandran, and Michael J Gresser, and Zheng Huang
January 2003, The Journal of biological chemistry,
Qingping Wang, and Daniel Dubé, and Richard W Friesen, and Tammy G LeRiche, and Kevin P Bateman, and Laird Trimble, and Joe Sanghara, and Rebecca Pollex, and Chidambaram Ramachandran, and Michael J Gresser, and Zheng Huang
October 2000, Biochemical pharmacology,
Copied contents to your clipboard!